Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)

A Single-masked, Placebo Controlled, Multi-center Pilot Study to Determine the Safety and Efficacy of Orbital Injections of a Fixed Dose of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease

This is a pilot study to determine the safety and efficacy of orbital injections of LIPO-102.

Inclusion Criteria:

• Male or Non pregnant female
• Symptomatic exophthalmos
• Inactive Thyroid Eye Disease
• Signed informed consent

Exclusion Criteria:

• Known hypersensitivity to study drugs
• Treatment with an investigational agent within 30 days of first dose
• History of Thyroid Eye Disease less than 6 months
• Previous decompression surgery
• Glaucoma